纳米颗粒介导的基因治疗的毒性和疗效的临床评估。
Clinical Evaluations of Toxicity and Efficacy of Nanoparticle-Mediated Gene Therapy.
机构信息
1 Department of Gynecology and Obstetrics, Development and Related Diseases of Women and Children, Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China .
2 Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China .
出版信息
Hum Gene Ther. 2018 Nov;29(11):1227-1234. doi: 10.1089/hum.2018.069. Epub 2018 Sep 5.
Abstract
Considerable efforts have been devoted to develop safe and efficient gene therapies for life-threatening or inherited diseases. The choice of gene delivery vehicle plays key roles in enhancing the therapeutic effect of nucleic acid cargo. To date, gene therapy approaches involving both viral vectors and nonviral vectors have been evaluated in clinical trials. With improvements in material science and nanotechnologies, positively charged nanoparticles have emerged as potential gene delivery vehicles. In this review, we highlight clinical trials that examined cationic nanocarrier-mediated gene therapy as well as discuss both the toxicity and efficacy of nanocarrier-based therapeutics.
摘要
人们投入了大量精力来开发安全有效的基因疗法，以治疗危及生命或遗传性疾病。基因传递载体的选择在提高核酸载药的治疗效果方面起着关键作用。迄今为止，涉及病毒载体和非病毒载体的基因治疗方法已经在临床试验中进行了评估。随着材料科学和纳米技术的进步，带正电荷的纳米颗粒已成为潜在的基因传递载体。在这篇综述中，我们重点介绍了评估阳离子纳米载体介导的基因治疗的临床试验，并讨论了基于纳米载体的治疗的毒性和疗效。
相似文献
1
Clinical Evaluations of Toxicity and Efficacy of Nanoparticle-Mediated Gene Therapy.纳米颗粒介导的基因治疗的毒性和疗效的临床评估。
Hum Gene Ther. 2018 Nov;29(11):1227-1234. doi: 10.1089/hum.2018.069. Epub 2018 Sep 5.
2
Lipid nanoparticles for gene delivery.用于基因递送的脂质纳米颗粒。
Adv Genet. 2014;88:13-36. doi: 10.1016/B978-0-12-800148-6.00002-X.
3
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration.非病毒癌症基因治疗：递药级联和载体纳米特性整合。
Adv Drug Deliv Rev. 2017 Jun 1;115:115-154. doi: 10.1016/j.addr.2017.07.021. Epub 2017 Aug 1.
4
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility.脂质纳米颗粒助力基因治疗：从理念到临床应用。
Nucleic Acid Ther. 2018 Jun;28(3):146-157. doi: 10.1089/nat.2018.0721. Epub 2018 Apr 23.
5
Surface modification of nonviral nanocarriers for enhanced gene delivery.用于增强基因递送的非病毒纳米载体的表面修饰
Nanomedicine (Lond). 2014 Jan;9(1):135-51. doi: 10.2217/nnm.13.194.
6
Vectors and strategies for nonviral cancer gene therapy.非病毒癌症基因治疗的载体与策略
Expert Opin Biol Ther. 2016;16(4):443-61. doi: 10.1517/14712598.2016.1134480. Epub 2016 Jan 13.
7
Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy.磷酸钙纳米颗粒：基因治疗中的第二代非病毒载体
Expert Rev Mol Diagn. 2005 Nov;5(6):893-905. doi: 10.1586/14737159.5.6.893.
8
Nanoparticle-based delivery system for application of siRNA in vivo.基于纳米颗粒的 siRNA 体内应用递释系统。
Curr Drug Metab. 2010 Feb;11(2):182-96. doi: 10.2174/138920010791110863.
9
Nanoparticle-mediated gene delivery.纳米颗粒介导的基因递送。
Methods Mol Biol. 2009;544:547-57. doi: 10.1007/978-1-59745-483-4_34.
10
Polymer-coated viral vectors: hybrid nanosystems for gene therapy.聚合物涂层病毒载体：用于基因治疗的杂交纳米系统。
J Gene Med. 2018 Apr;20(4):e3011. doi: 10.1002/jgm.3011. Epub 2018 Mar 25.
引用本文的文献
1
Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?假型慢病毒载体：准备好转化为靶向癌症基因治疗了吗？
Genes Dis. 2022 Apr 2;10(5):1937-1955. doi: 10.1016/j.gendis.2022.03.007. eCollection 2023 Sep.
2
Large-scale Isolation of Exosomes Derived from NK Cells for Anti-tumor Therapy.用于抗肿瘤治疗的自然杀伤细胞来源外泌体的大规模分离
Bio Protoc. 2023 Jun 5;13(11):e4693. doi: 10.21769/BioProtoc.4693.
3
Optimization of 5'UTR to evade SARS-CoV-2 Nonstructural protein 1-directed inhibition of protein synthesis in cells.优化 5'UTR 以规避 SARS-CoV-2 非结构蛋白 1 对细胞中蛋白质合成的抑制作用。
Appl Microbiol Biotechnol. 2023 Apr;107(7-8):2451-2468. doi: 10.1007/s00253-023-12442-2. Epub 2023 Feb 27.
4
NK cell-derived exosomes enhance the anti-tumor effects against ovarian cancer by delivering cisplatin and reactivating NK cell functions.自然杀伤细胞衍生的外泌体通过递送顺铂和重新激活自然杀伤细胞功能增强对卵巢癌的抗肿瘤作用。
Front Immunol. 2023 Jan 19;13:1087689. doi: 10.3389/fimmu.2022.1087689. eCollection 2022.
5
Sustained Drug Release from Smart Nanoparticles in Cancer Therapy: A Comprehensive Review.癌症治疗中智能纳米颗粒的药物持续释放：综述
Micromachines (Basel). 2022 Sep 28;13(10):1623. doi: 10.3390/mi13101623.
6
Design of Smart Nanodiamonds: Introducing pH Sensitivity to Improve Nucleic Acid Carrier Efficiency of Diamoplexes.智能纳米金刚石的设计：引入pH敏感性以提高核酸载体二聚体的效率
Pharmaceutics. 2022 Aug 26;14(9):1794. doi: 10.3390/pharmaceutics14091794.
7
Nanotechnologies in Obstetrics and Cancer during Pregnancy: A Narrative Review.孕期产科与癌症中的纳米技术：一项叙述性综述
J Pers Med. 2022 Aug 17;12(8):1324. doi: 10.3390/jpm12081324.
8
Cationic Nanomaterials for Autoimmune Diseases Therapy.用于自身免疫性疾病治疗的阳离子纳米材料
Front Pharmacol. 2022 Jan 21;12:762362. doi: 10.3389/fphar.2021.762362. eCollection 2021.
9
Non-viral vectors for RNA delivery.非病毒载体的 RNA 递送。
J Control Release. 2022 Feb;342:241-279. doi: 10.1016/j.jconrel.2022.01.008. Epub 2022 Jan 10.
10
Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease.纳米颗粒用于核酸治疗的机遇与挑战：首款用于治疗罕见病的RNAi纳米颗粒获批
Natl Sci Rev. 2019 Nov;6(6):1105-1106. doi: 10.1093/nsr/nwz009. Epub 2019 Feb 5.
本文引用的文献
1
Negative regulation of cationic nanoparticle-induced inflammatory toxicity through the increased production of prostaglandin E2 via mitochondrial DNA-activated Ly6C monocytes.通过激活 Ly6C 单核细胞增加前列腺素 E2 的产生来负调控阳离子纳米颗粒诱导的炎症毒性。
Theranostics. 2018 May 6;8(11):3138-3152. doi: 10.7150/thno.21693. eCollection 2018.
2
Current Status of Nonviral Vectors for Gene Therapy in China.中国基因治疗中非病毒载体的现状。
Hum Gene Ther. 2018 Feb;29(2):110-120. doi: 10.1089/hum.2017.226.
3
The Immune Function of Ly6Chi Inflammatory Monocytes During Infection and Inflammation.感染和炎症期间Ly6Chi炎性单核细胞的免疫功能
Curr Mol Med. 2017;17(1):4-12. doi: 10.2174/1566524017666170220102732.
4
Treatment of dextran sodium sulfate-induced experimental colitis by adoptive transfer of peritoneal cells.通过腹腔细胞的过继转移治疗葡聚糖硫酸钠诱导的实验性结肠炎。
Sci Rep. 2015 Nov 13;5:16760. doi: 10.1038/srep16760.
5
RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients.针对KRAS的RNA干扰疗法联合化疗用于局部晚期胰腺癌患者。
Oncotarget. 2015 Sep 15;6(27):24560-70. doi: 10.18632/oncotarget.4183.
6
Cationic nanocarriers induce cell necrosis through impairment of Na(+)/K(+)-ATPase and cause subsequent inflammatory response.阳离子纳米载体通过损害钠钾ATP酶诱导细胞坏死，并引发随后的炎症反应。
Cell Res. 2015 Feb;25(2):237-53. doi: 10.1038/cr.2015.9. Epub 2015 Jan 23.
7
Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA.将动物和人体 Ia/Ib 期临床试验数据与靶向聚合物纳米颗粒载 siRNA 的 CALAA-01 进行关联。
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11449-54. doi: 10.1073/pnas.1411393111. Epub 2014 Jul 21.
8
Non-viral vectors for gene-based therapy.基于基因治疗的非病毒载体。
Nat Rev Genet. 2014 Aug;15(8):541-55. doi: 10.1038/nrg3763. Epub 2014 Jul 15.
9
Deliver on a promise.兑现承诺。
Sci Am. 2014 Jul;311(1):S12-3.
10
A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group study.一项评估 PEG-PEI-胆固醇脂质体包载的 IL-12 质粒 EGEN-001 腹腔给药治疗持续性或复发性上皮性卵巢癌、输卵管癌或原发性腹膜癌的 II 期临床试验：妇科肿瘤学组研究。
Gynecol Oncol. 2014 Jun;133(3):433-8. doi: 10.1016/j.ygyno.2014.03.571. Epub 2014 Apr 4.
Zotero 插件